Literature DB >> 8675740

Hepatitis C virus seroconversion by a third generation ELISA screening test in blood donors.

H I Atrah1, M M Ahmed.   

Abstract

The significance of seroconversion as detected by an ELISA screening test for hepatitis C virus (HCV) antibody with a negative supplemental/confirmatory recombinant immunoblot assay (RIBA) result was investigated. Of 118,220 established West Midlands blood donors with at least one negative HCV antibody screen, 43 had seroconverted in 1994 according to the ELISA but had negative RIBA-3 results. The paired archive serum samples of the pre- and postseroconversion donations of 29 seroconverting donors were tested by nested polymerase chain reaction (PCR) for the detection of HCV RNA. All 58 samples were negative by PCR. The absence of detectable viraemia in all tested seroconverting donors suggests that HCV infection was not responsible for seroconversion by ELISA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675740      PMCID: PMC500409          DOI: 10.1136/jcp.49.3.254

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Hepatitis C virus seroconversion rate in established blood donors.

Authors:  H I Atrah; F Hutchinson; D Gough; F A Ala; M M Ahmed
Journal:  J Med Virol       Date:  1995-08       Impact factor: 2.327

2.  Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays.

Authors:  A M Couroucé; N Le Marrec; A Girault; S Ducamp; N Simon
Journal:  Transfusion       Date:  1994-09       Impact factor: 3.157

3.  Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.

Authors:  L H Tobler; M P Busch; J Wilber; R Dinello; S Quan; A Polito; R Kochesky; C Bahl; M Nelles; S R Lee
Journal:  Transfusion       Date:  1994-02       Impact factor: 3.157

4.  Evaluation of third-generation screening and confirmatory assays for HCV antibodies.

Authors:  S Uyttendaele; H Claeys; W Mertens; H Verhaert; C Vermylen
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

  4 in total
  2 in total

1.  Gold aggregating gold: A novel nanoparticle biosensor approach for the direct quantification of hepatitis C virus RNA in clinical samples.

Authors:  Sherif M Shawky; Ahmed M Awad; Walaa Allam; Mohamed H Alkordi; Sherif F El-Khamisy
Journal:  Biosens Bioelectron       Date:  2016-11-04       Impact factor: 10.618

2.  A Novel Structurally Stable Multiepitope Protein for Detection of HCV.

Authors:  Alexsandro S Galdino; José C Santos; Marilen Q Souza; Yanna K M Nóbrega; Mary-Ann E Xavier; Maria S S Felipe; Sonia M Freitas; Fernando A G Torres
Journal:  Hepat Res Treat       Date:  2016-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.